PMV Pharmaceuticals (PMVP) Insider Trading & Ownership → AI to Meet the Same Fate as EVs? (From Porter & Company) (Ad) Free PMVP Stock Alerts $1.70 +0.05 (+3.03%) (As of 04:00 PM ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media PMV Pharmaceuticals (NASDAQ:PMVP) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage7.60%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)2Amount OfInsider Selling(Last 12 Months)$222,931.26 Get PMVP Insider Trade Alerts Want to know when executives and insiders are buying or selling PMV Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address PMVP Insider Buying and Selling by Quarter Ad Porter & CompanyAI to Meet the Same Fate as EVs? When these tech bubbles burst, they invariably leave investors disillusioned by their losses. Now, many worry a similar fate is awaiting AI. And one man, legendary financial analyst Porter Stansberry, who called Nvidia at $11… Simply click here to read Porter’s warning on The Big AI Die-Up now. PMV Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/22/2023Orbimed Advisors LlcMajor ShareholderSell87,786$2.23$195,762.78 9/15/2023Deepika JalotaInsiderSell4,104$6.62$27,168.48 (Data available from 1/1/2013 forward) PMVP Insider Trading Activity - Frequently Asked Questions Who is on PMV Pharmaceuticals's Insider Roster? The list of insiders at PMV Pharmaceuticals includes Arnold J Levine, David Henry Mack, Deepika Jalota, Euclidean Capital Llc, Leila Alland, Orbimed Advisors Llc, Richard A Heyman, Thilo Schroeder, and Winston Kung. Learn more on insiders at PMVP. What percentage of PMV Pharmaceuticals stock is owned by insiders? 7.60% of PMV Pharmaceuticals stock is owned by insiders. Learn more on PMVP's insider holdings. Which PMV Pharmaceuticals insiders have been selling company stock? The following insiders have sold PMVP shares in the last 24 months: Deepika Jalota ($27,168.48), and Orbimed Advisors Llc ($9,199,138.07). How much insider selling is happening at PMV Pharmaceuticals? Insiders have sold a total of 517,643 PMV Pharmaceuticals shares in the last 24 months for a total of $9,226,306.55 sold. More Insider Trading Tools from MarketBeat Related Companies: CMRX Insider Transactions CUE Insider Transactions LFVN Insider Transactions ETON Insider Transactions VERU Insider Transactions BTAI Insider Transactions ACRS Insider Transactions VAXX Insider Transactions VACC Insider Transactions LTRN Insider Transactions Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 3 Stocks Insiders Are Buying That Analysts LoveInsider Selling of Amazon Spikes in Q1, but it's Not Time to Sell3 Small Dividend Paying Banks Insiders are Buying3 Stocks Insiders are Buying at New HighsInsider selling at JPM: A Closer Look Amidst Historic CEO Sale This page (NASDAQ:PMVP) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersGrab Your Free Bitcoin Today!Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders Alliance“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryMost important medical advance in 100 yearsThe Oxford ClubFed launches fourth dollar overhaulStansberry ResearchBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the MarketsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PMV Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.